Genmab — November 2018

[Bulder]

Der kører flere forsøg med dara i MDS, så en dag bliver dara vel godkendt her. Om der skal en speciel godkendelse til at behandle komplikationen ved jeg ikke.

[peter12]

Ok jeg troede det var generelt ved transplantation (knoglemarv) og AB0 mismatch...

[E_L]

i wonder if we get to learn more about this, if it can be used more broadly with blood incompatibility in other circumstances .

[Bulder]

Exactly. In this specific case it was anemia after an allogeneic transplant. But PRCA is concidered an autoimmune decease, that can have many other causes. So maybe dara can play a role there.

[Parasitism]

Kom så - luk lige over 1.000

[Bulder]

desease

[E_L]

1 more try

[Bulder]

ok then
disease

[peter12]

Der blev lukket shorts i 1013

[PrivatInvestor84]

Looks like a close above 1.000

[GeorgeBest]

https://twitter.com/mtmdphd/status/1060290126834819072?s=21

[bibob]

God morgen. Og god weekend.

[polle1]

God morgen, god dag og god weekend

[Parasitism]

God morgen

[peter12]

Der er også nogen der bliver tørret i dag

[Helge_LarsenPI-redaktør]

Just a moment...

(www.proinvestor.com)

[E_L]

New trial: Daratumumab, Bortezomib, and Dexamethasone With or Without Venetoclax https://clinicaltrials.gov/ct2/show/NCT03701321?term=NCT03701321&rank=1

[E_L]

it's a shame they don't yet start using SC in these new trials. Note though MRD as primary outcome.

[Sukkeralf]

they probably need sc dosing approved first

[bibob]

I think you are right Sukkeralf,!! - but when approved do you then think that they can change the study to use sc instead of iv. It looks like that sc has a better safety profile than iv !! - or am I wrong ??